Glycemic variability and reference percentiles in very low birth weight preterm infants using continuous glucose

Irene Gutiérrez-Rosa1, Manuel Lubián-Gutiérrez1,2, Carmen Rodríguez-Barrios1,2

  • 1Biomedical Research and Innovation Institute of Cádiz (INiBICA), Puerta del Mar University Hospital, Cádiz, Spain.

Plos One
|March 27, 2026
PubMed

Insights

Managing blood glucose in very-low-birth-weight preterm infants is complex. This study provides gestational-age-specific glucose reference ranges for the first 14 days, aiding individualized care for these vulnerable infants.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Metabolic Adaptation

Background:

  • Glycemic control is challenging in very-low-birth-weight preterm infants due to immature glucose homeostasis.
  • The first two weeks of life are critical for metabolic adaptation, showing high glucose variability.
  • Continuous glucose monitoring is essential for tracking trends in this vulnerable population.

Purpose of the Study:

  • To describe daily glucose patterns and variability in preterm infants during the first 14 postnatal days.
  • To generate gestational-age-specific reference percentiles for clinically stable preterm infants.
  • To support individualized glucose management strategies in neonatal intensive care.

Main Methods:

  • A prospective observational study involving 103 clinically stable preterm infants (24-32 weeks gestational age).
  • Continuous glucose monitoring was performed during the first 14 days of life.
  • Infants were classified into three gestational age groups for analysis.

Main Results:

  • Mean glucose concentrations and variability decreased with postnatal age across all groups.
  • Infants born at 24-26 weeks showed higher mean glucose and greater variability compared to more mature groups.
  • Gestational-age-specific reference percentiles for glucose levels were established for days 1 and 14.

Conclusions:

  • Glucose levels and variability naturally decrease in preterm infants during the first two weeks of life.
  • The least mature preterm infants (24-26 weeks) exhibit higher and more variable glucose concentrations.
  • These gestational-age-specific reference percentiles derived from continuous monitoring can inform personalized glucose management.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
5.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.4K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
37.3K